secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2023-12-22T23:59:59+00:00
Accession:  0001809519-23-000062
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx appoints Kelly J. Kennedy to Board of Directors, fills vacancy
---------------------------------------------------------------------

- Kennedy elected as Class I director effective Dec 21, 2023; term expires at 2024 annual meeting.
- She replaces Jacqueline Kosecoff and will serve on the Audit Committee.
- Kennedy is former CFO of The Honest Company and Willow Innovations; over 25 years experience.
- Received initial RSU award valued at $420,000, vesting over three years.
- Board adopted Deferred Compensation Plan for non-employee directors, effective Jan 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951923000062/0001809519-23-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951923000062/gdrx-20231221.htm
  HTML page:      https://secwatch.observer/filing/0001809519-23-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer